Treatment patterns and outcomes with HER2-directed therapy for the treatment of HER2-positive metastatic breast cancer.

被引：0
|
作者：
Luthra, Rakesh
Fisher, Maxine
Brammer, Melissa
Lalla, Deepa
机构：
[1] HealthCore Inc, Wilmington, DE USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11063
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Therapy for HER2-Positive Metastatic Breast Cancer REPLY
    Winer, Eric P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25):
  • [32] Trastuzumab therapy in HER2-positive, metastatic breast cancer
    Smith, A. D.
    Guilbert, K.
    Lister, D.
    Streilein, S.
    Bourrier, V. C.
    Lozar, B.
    Navaratnam, S.
    Harding, G. A.
    Pitz, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Therapy of cerebral metastatic, HER2-positive Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (11)
  • [34] Systemic therapy for metastatic HER2-positive breast cancer
    Bredin, Philip
    Walshe, Janice M.
    Denduluri, Neelima
    SEMINARS IN ONCOLOGY, 2020, 47 (05) : 259 - 269
  • [35] Safety and efficacy of gemcitabine and trastuzumab in HER2-directed therapy pretreated patients with HER2-positive metastatic breast cancer: SBP-01 study.
    Yoshitomi, Seiji
    Tsuji, Hisashi
    Ikeda, Masahiko
    Ito, Mitsuya
    Ohtani, Shoichiro
    Higaki, Kenji
    Sagawa, Teiri
    Matsuoka, Kinya
    Kawai, Hiroshi
    Takabatake, Daisuke
    Doihara, Hiroyoshi
    Shien, Tadahiko
    Taira, Naruto
    Ohtawa, Yasuyuki
    Maruyama, Shuichiro
    Hikino, Hajime
    Fujii, Sayaka
    Yamamoto, Yutaka
    Ohsumi, Shozo
    Hara, Fumikata
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [36] Progression and treatment of HER2-positive breast cancer
    April Davoli
    Barbara A. Hocevar
    Thomas L. Brown
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 611 - 623
  • [37] Optimizing Treatment of HER2-Positive Breast Cancer
    Gradishar, William J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (5.5): : 649 - 651
  • [38] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [39] Adjuvant treatment for HER2-positive breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2015, 16 (02): : E59 - E59
  • [40] Treatment Combinations for HER2-Positive Breast Cancer
    Pegram, Mark
    ONCOLOGY-NEW YORK, 2013, 27 (04): : 258 - +
12345